| 000 | 01315 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517133856.0 | ||
| 264 | 0 | _c20170518 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1747-4094 | ||
| 024 | 7 |
_a10.1080/17474086.2017.1283214 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNandagopal, Lakshminarayanan | |
| 245 | 0 | 0 |
_aTreatment approaches of hard-to-treat non-Hodgkin lymphomas. _h[electronic resource] |
| 260 |
_bExpert review of hematology _cMar 2017 |
||
| 300 |
_a259-273 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aGenes, bcl-2 |
| 650 | 0 | 4 | _aGenes, myc |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdiagnosis |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-6 _xgenetics |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetreatment |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMehta, Amitkumar | |
| 773 | 0 |
_tExpert review of hematology _gvol. 10 _gno. 3 _gp. 259-273 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17474086.2017.1283214 _zAvailable from publisher's website |
| 999 |
_c26791286 _d26791286 |
||